Indivior PLC (INDV)
NASDAQ: INDV · Real-Time Price · USD
31.09
-0.78 (-2.45%)
Nov 7, 2025, 1:40 PM EST - Market open
Indivior Market Cap
Indivior has a market cap or net worth of $3.88 billion as of November 7, 2025. Its market cap has increased by 247.61% in one year.
Market Cap
3.88B
Enterprise Value
3.81B
1-Year Change
247.61%
Ranking
Category
Stock Price
$31.09
Market Cap Chart
Since December 29, 2014, Indivior's market cap has increased from $1.53B to $3.88B, an increase of 153.61%. That is a compound annual growth rate of 8.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2025 | 3.98B | 156.16% |
| Dec 31, 2024 | 1.55B | -25.50% |
| Dec 29, 2023 | 2.09B | -29.77% |
| Dec 29, 2022 | 2.97B | 22.55% |
| Dec 31, 2021 | 2.42B | 125.44% |
| Dec 31, 2020 | 1.07B | 182.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 839.37B |
| Johnson & Johnson | 450.47B |
| AbbVie | 387.13B |
| UnitedHealth Group | 291.28B |
| AstraZeneca | 260.82B |
| Novartis AG | 242.27B |
| Abbott Laboratories | 217.27B |
| Merck & Co. | 212.91B |